1 | Density | 5.41% | |
2 | Sustained | 2.7% | |
3 | Plasma | 2.7% | |
4 | ccRCC | 2.7% | |
5 | Australia | 2.7% | |
6 | BreastScreen | 2.7% | |
7 | Age | 2.7% | |
8 | Exchange | 2.7% | |
9 | High | 2.7% | |
10 | Step | 2.7% | |
11 | Leader | 2.7% | |
12 | Health | 2.7% | |
13 | Women | 2.7% | |
14 | Breast | 2.7% | |
15 | Lowering | 2.7% | |
16 | Adjuvant | 2.7% | |
17 | Volpara | 2.7% | |
18 | Measurement | 2.7% | |
19 | DFS | 2.7% | |
20 | Data | 2.7% | |
21 | Benefit | 2.7% | |
22 | Pembrolizumab | 2.7% | |
23 | Blood | 2.7% | |
24 | Recommended | 2.7% | |
25 | Long-Term | 2.7% | |
26 | Humans | 2.7% | |
27 | Best | 2.7% | |
28 | Rule | 2.7% | |
29 | AI-assisted | 2.7% | |
30 | Demonstrate | 2.7% | |
31 | Reporting | 2.7% | |
32 | Biological | 2.7% | |
33 | Tea | 2.7% | |
34 | Pressure | 2.7% | |
35 | Critical | 2.7% | |
36 | Reduces | 2.7% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|